Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Forte Biosciences Inc FBRX

Healthcare Biotechnology
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases. The Company is advancing its product candidate, FB-102, which is a proprietary molecule with potentially broad autoimmune applications, including in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA). The Company’s FB-102 program... see more

Bullboard (NDAQ:FBRX)

View:
1 2 Next
Post by AlphaSurge34on Nov 29, 2024 8:43am

Forte Biosciences: Biotech with Explosive Potential

Forte’s trial results are turning heads, and institutional investors are starting to take notice. With the right backing, a 2–3x move from here isn’t just possible—it’s likely. The biotech sector ...more  
7
Post by ChartXplorer99on Nov 28, 2024 3:02pm

FBRX Eyes $20 Level, $MYNZ Riding Sector Strength

$FBRX is consolidating near $20 resistance, forming a potential bull flag. Eyes on a breakout. $MYNZ continues to thrive, with strong volume intraday and +5% in the after-hours. Momentum remains solid ...more  
17
Post by MarketHaven44on Nov 27, 2024 4:31pm

Biotech Traders, FBRX Is in Play

FBRX has all the ingredients for a run—cash infusion, insider backing, and a solid trial pipeline. Volatility is high, but this is biotech gold for swing traders.
11
Post by PulseCapital19on Nov 27, 2024 4:24pm

FBRX: Small Cap, Big Moves

FBRX’s low float and fresh funding are the perfect combo for traders looking for action. With its trial pipeline looking solid, this could be more than just a pop.
12
Post by ChartHawk92on Nov 27, 2024 4:17pm

FBRX's Financials Show Solid Foundation

FBRX's P/B ratio of 2.99 indicates a solid financial base. With a $53M cash infusion, the company is well-positioned for growth. Keep this biotech on your watchlist!
14
Post by NovaGain47on Nov 27, 2024 4:06pm

FBRX's Institutional Support Grows

Top institutional players like OrbiMed and Janus Henderson are backing FBRX's $53M private placement. This strong support could propel the stock higher.
20
Post by TitanEquity52on Nov 27, 2024 4:00pm

FBRX's Insider Moves Signal Confidence

Insiders are holding 16.75% of FBRX shares, showing they're betting big on the company's future. With institutions holding 53.94%, this stock's got serious backing. Watch for the next move ...more  
13
Post by TradeVanguard27on Nov 27, 2024 3:53pm

FBRX Rockets on $53M Cash Infusion

FBRX scored a $53M private placement, and the stock's on fire! This cash boost is set to fuel their autoimmune drug, FB102. Bulls are loving the momentum—keep an eye on this one!
16
Post by RapidEdge43on Nov 27, 2024 11:38am

Breakout Potential in $FBRX, $MYNZ Gaining Volume

$FBRX is closing in on the key $18 level, a breakout zone that could trigger significant upside if crossed. The chart shows bullish momentum building, making it one to watch closely. Meanwhile, $MYNZ ...more  
15
Post by TurbWealth35on Nov 26, 2024 7:37am

Bullish Flag Forming in $FBRX and $MYNZ Long Setup

$FBRX is showing strength with a clean bullish flag setup—watch for a breakout above $18 to trigger the next leg higher. With no short float, it’s all about momentum. Meanwhile, $MYNZ is looking like ...more  
16
Post by TurbWealth35on Nov 26, 2024 7:36am

Bullish Flag Forming in $FBRX and $MYNZ Long Setup

$FBRX is showing strength with a clean bullish flag setup—watch for a breakout above $18 to trigger the next leg higher. With no short float, it’s all about momentum. Meanwhile, $MYNZ is looking like ...more  
18
Post by HorizonWealth32on Nov 25, 2024 4:07pm

Fundamental Focus: $FBRX and $MYNZ

$FBRX is forming a bullish flag just below $18, with potential to test $19 on a breakout—momentum is building. Meanwhile, $MYNZ is building a solid base at 0.20, showing steady accumulation. Volume ...more  
32
Post by ApexWealth99on Nov 25, 2024 10:20am

Bullish Setups in $FBRX and $MYNZ

$FBRX is forming a bullish flag near $16 after its recent breakout, with consolidation suggesting another leg up. $MYNZ gains attention ahead of the FDA's GenAI conference, highlighting its ...more  
19
Post by ApexTrader65on Nov 25, 2024 10:12am

Momentum Plays: $FBRX and $MYNZ

$FBRX’s flag formation around $16 shows strong bullish potential—watch for a breakout confirmation. Meanwhile, $MYNZ eyes growth catalysts as it aligns with discussions at the FDA GenAI conference on ...more  
18
Post by BullishEdge56on Nov 20, 2024 4:08pm

Hot Stock Alert: $FBRX Rallies on Fresh Funding News

$FBRX made a very strong move through the 50-day moving average on news of a $53 million funding infusion. Added to my watchlist.
18
1 2 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities